Ultragenyx Pharmaceutical

👥 501-1000💰 $350,000,000 Post-IPO Equity 8 months agoPharmaceuticalBiotechnologyHealth Care📈 Public Company
Website LinkedIn Email Twitter

Ultragenyx Pharmaceutical is a biotechnology company focused on discovering and developing novel products for the treatment of rare and debilitating diseases.

Related companies: